Natela Shanidze

Visual/vestibular scientist @SKERIResearch. @NGPMichigan & @UChicagoCollege alumna. Proud Ukrainian 🇺🇦🌻

[Natela Shanidze @VestiVisiLab]

I wrote this a bit less than a year ago. This #MothersDay, it's my ardent wish that there is less and less need for things like this to be written https://t.co/AEPuWwVG0t

[SfN Journals @SfNJournals]

#eNeuro: Findings from García-Lázaro and Teng show that the brain distinguishes between real and synthetic reverberation. This provides insights for enhancing realism in immersive virtual reality, music, and film production and using reverberation to guide navigation for blind and visually impaired people. @SKERIResearch
https://t.co/F1LAo8cbqt

[Smith-Kettlewell Eye Research Institute @SKERIResearch]

Visual illusions enter the political arena in this allusion to the scramble of 3D Magic Eye field emerging into a clear 3D image. The Magic Eye concept was developed @SKERIResearch by Dr. Christopher Tyler and is still providing popular and scientific insights today. 🗳️

[Natela Shanidze @VestiVisiLab]

@MariyaSweetwyne Very tempting! Anything that gets us more chances to hang out!

[Natela Shanidze @VestiVisiLab]

@MariyaSweetwyne Say hi to my conference friend!!

[Natela Shanidze @VestiVisiLab]

@Toby_Ellmers It was the Associate Editor, but the decision came from the EiC, so I suspect we are done here. As a Reviewer I feel like I would be very frustrated to have put all this effort towards review to be completely overridden.

[Natela Shanidze @VestiVisiLab]

Nothing like the joy of seeing all Reviewers sign off on a paper revision as "accept" to then have the Editor wish it was actually a totally different paper and reject it.

[Dr. J. M. Groh @JMGrohNeuro]

Hey NRSA recipients, this is the heroine who your awards are named after 👇💕

[Smith-Kettlewell Eye Research Institute @SKERIResearch]

In a recent @Freakonomics podcast, we heard about the economics of Botox and it's inventor and SKERI founder Alan Scott
https://t.co/lO5dWA4hll

[Natela Shanidze @VestiVisiLab]

@catgyoung Me! 🙋

[Natela Shanidze @VestiVisiLab]

@MariyaSweetwyne Ooooh, I love it! But I have questions on Innovation and Significance. Rescue from what? And is this a ploy to move you guys to FL?

[Natela Shanidze @VestiVisiLab]

Wish we were there!!

[Natela Shanidze @VestiVisiLab]

Excited to @attendWOC to present some of our research on mobility and falls in central visual field loss. #WOC2024

[Natela Shanidze @VestiVisiLab]

@MariyaSweetwyne I had to do a thorough photo check to figure out which kind of Georgian :P

[Dr. Glaucomflecken @DGlaucomflecken]

This is possibly the greatest moment for glasses in Olympic history

[Natela Shanidze @VestiVisiLab]

@MariyaSweetwyne @chrstn_e Oh man, I would have never been able to get a K99 (definitely helped launch me to independence) if it had a 2 yr cutoff. A bad postdoc, a field change, a kid, working with a population that takes time to recruit, & to be honest just a better understanding of all the moving parts.

[Natela Shanidze @VestiVisiLab]

@DGlaucomflecken Was just reading this gem yesterday in a study on maculopathies...

[Smith-Kettlewell Eye Research Institute @SKERIResearch]

Bill Gerrey, a pioneer in the blind accessibility space and a beloved member of our community passed away last October. We honor his legacy with the Blind Makers' Fund focused on supporting blind makers, inventors, & innovators. Join our campaign today! https://t.co/EqLsMjKLLn

[Dr.Yassine.Balhi @DoctorYassine]

Human Temporal bone dissection 👂
I think I’ve put a lot of love into this one ❤️

@LauerLab @WardensMD @hopkins_ent
#otopathology #otology #neurotology

[Natela Shanidze @VestiVisiLab]

A pandemic+ later, our study "Smooth pursuit deficits impact dynamic visual acuity in macular degeneration" is finally out! We further examine PRL use in pursuit and show that it's gain, not retinal pursuit location that affects target discrimination.
https://t.co/P6aSdAWAbv

[Natela Shanidze @VestiVisiLab]

@MariyaSweetwyne We call one of mine a baleen whale due to his ability to detect and reject all non-approved ingredients, even when cleverly blended in.